DTIL

#3729
Precision BioSciences, Inc. Common Stock
7.23 USD
+1.40%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
7.23
7.27
년간 변동
3.53
8.82
일일 변동
+1.40%
월간 변동
+27.51%
6달 변화
+22.34%
년간 변동율
+37.71%
이전 종가
7.13
Open
7.25
Bid
Ask
Low
7.23
High
7.27
양
31
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 178.77 M
  • Employee 68
  • Founded 2006
  • CEO N/A
  • Website www.precisionbiosciences.com
  • Headquarter Delaware, United States
  • FIGI BBG008NSBPV3
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.17
Price to sales ratio
1.56

Precision BioSciences Inc

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

뉴스